Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger

ConditionInfertility

Trial statusNot yet recruiting

Trial phasePhase 2

Trial typeInterventional

Biological sexFemale

Age18-40

SponsorBedaya Hospital

About this trial

The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation

Eligibility criteria

Qualifiers

POSEIDON group 3 and 4

GnRH antagonist IVF cycle

Disqualifiers

Hypogonadotrophic hypogonadism

Endometriosis

History of recurrent abortion

Trial design

Treatments tested in this trial

Double trigger
HCG trigger

Treatment groups

164 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Bedaya Hospital

Lead sponsor

Source ClinicalTrials.gov